The olfactory bulbectomised rat as a model of depression

被引:551
作者
Song, C
Leonard, BE
机构
[1] Canada Natl Inst Nutrisci & Hlth, Charlottetown, PE C1A 5TI, Canada
[2] Univ Prince Edward Isl, Dept Biomed Sci, AVC, Charlottetown, PE, Canada
[3] Natl Univ Ireland Univ Coll Galway, Galway, Ireland
[4] Univ Maastricht, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
关键词
olfactory bulbectomy; limbic system; depression; behavior; immune changes; neurotransmitter changes; antidepressants;
D O I
10.1016/j.neubiorev.2005.03.010
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Bilateral olfactory bulbectomy results in changes in behavior, and in the endocrine, immune and neurotransmitter systems, that simulates many of those seen in patients with major depression. The olfactory system in the rat forms a part of the limbic region in which the amygdala and hippocampus contribute to the emotional and memory components of behavior. However, the loss of olfaction alone, which results from bulbectomy, is not the major factor that contributes to the behavioral abnormalities as peripherally induced anosmia does not cause the same behavioral changes. Thus it would appear that bulbectomy causes a major dysfunction of the cortical-hippocampal-amygdala circuit that underlies the behavioral and other changes. These neuroanatomical areas also seem to be dysfunctional in the patient with major depression. Chronic, but not acute, administration of antidepressants largely corrects most the behavioral, endocrine, immune and neurotransmitter changes that occur following bulbectomy. Thus the olfactory bulbectomized rat is not only a model for detecting antidepressant activity but also one for exploring the inter-relationships between these systems that are also dysfunctional in patients with major depression. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:627 / 647
页数:21
相关论文
共 240 条
[31]   Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1β in the rat [J].
Castanon, N ;
Bluthé, RM ;
Dantzer, R .
PSYCHOPHARMACOLOGY, 2001, 154 (01) :50-60
[33]   Olfactory bulbectomy provokes a suppression of interleukin-1β and tumour necrosis factor-α production in response to an in vivo challenge with lipopolysaccharide:: Effect of chronic desipramine treatment [J].
Connor, TJ ;
Harkin, A ;
Kelly, JP ;
Leonard, BE .
NEUROIMMUNOMODULATION, 2000, 7 (01) :27-35
[34]   Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat [J].
Connor, TJ ;
Kelliher, P ;
Harkin, A ;
Kelly, JP ;
Leonard, BE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 379 (2-3) :125-133
[35]   Stressor-induced alterations in serotonergic activity in an animal model of depression [J].
Connor, TJ ;
Song, C ;
Leonard, BE ;
Anisman, H ;
Merali, Z .
NEUROREPORT, 1999, 10 (03) :523-528
[36]  
COWEN PJ, 1993, CLIN NEUROPHARMACOL, V16, pS6
[37]   5-HT(1A) RECEPTOR SENSITIVITY IN MAJOR DEPRESSION - A NEUROENDOCRINE STUDY WITH BUSPIRONE [J].
COWEN, PJ ;
POWER, AC ;
WARE, CJ ;
ANDERSON, IM .
BRITISH JOURNAL OF PSYCHIATRY, 1994, 164 :372-379
[38]   Assessing antidepressant activity in rodents: recent developments and future needs [J].
Cryan, JF ;
Markou, A ;
Lucki, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (05) :238-245
[39]   Combining pindolol and paroxetine in an animal model of chronic antidepressant action - can early onset of action be detected? [J].
Cryan, JF ;
McGrath, C ;
Leonard, BE ;
Norman, TR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 352 (01) :23-28
[40]   The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat [J].
Cryan, JF ;
Redmond, AM ;
Kelly, JP ;
Leonard, BE .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 (02) :109-114